Feedback / Questions
BDTX-1535 - Black Diamond Therap
https://www.onclive.com/view/halmos-highlights-evaluation-of-the-egfr-inhibitor-bdtx-1535-in-nsclc
Courtney Flaherty; Balazs Halmos
Nov 16, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next